Simultaneous Subconjunctival Triamcinolone and Bevacizumab Injections for Management of Blepharokeratoconjunctivitis in Children

PURPOSE: To report the efficacy of subconjunctival triamcinolone (Kenalog A-40, Alcon) and bevacizumab (Avastin, Genentech) injections in fraternal twins with blepharokeratoconjunctivitis (BKC) causing progressive, bilateral corneal neovascularization and scarring. METHODS: In this retrospective obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Chu Luan, Chen, Tony S., Tran, Khoi, Smith, James E. H., Lewis, Noni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008772/
https://www.ncbi.nlm.nih.gov/pubmed/29967706
http://dx.doi.org/10.1155/2018/2602487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008772/
https://www.ncbi.nlm.nih.gov/pubmed/29967706
http://dx.doi.org/10.1155/2018/2602487

Ejemplares similares